<VariationArchive VariationID="17425" VariationName="NM_000094.4(COL7A1):c.2471dup (p.Asn825fs)" VariationType="Duplication" Accession="VCV000017425" Version="13" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-15" DateCreated="2013-04-04" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32464" VariationID="17425">
      <GeneList>
        <Gene Symbol="COL7A1" FullName="collagen type VII alpha 1 chain" GeneID="1294" HGNC_ID="HGNC:2214" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48564073" stop="48595329" display_start="48564073" display_stop="48595329" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48601505" stop="48632592" display_start="48601505" display_stop="48632592" Strand="-" />
          </Location>
          <OMIM>120120</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000094.4(COL7A1):c.2471dup (p.Asn825fs)</Name>
      <CanonicalSPDI>NC_000003.12:48588757:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48588757" stop="48588758" display_start="48588757" display_stop="48588758" variantLength="1" positionVCF="48588757" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48626190" stop="48626191" display_start="48626190" display_stop="48626191" variantLength="1" positionVCF="48626190" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>N825fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.3" sequenceAccession="NM_000094" sequenceVersion="3" change="c.2471dupG">
            <Expression>NM_000094.3:c.2471dupG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.3" sequenceAccession="NM_000094" sequenceVersion="3" change="c.2471dup">
            <Expression>NM_000094.3:c.2471dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48626192dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48626192dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48588759dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48588759dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007065.1" sequenceAccession="NG_007065" sequenceVersion="1" change="g.11495dup">
            <Expression>NG_007065.1:g.11495dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_099352.1" sequenceAccession="NG_099352" sequenceVersion="1" change="g.530dup">
            <Expression>NG_099352.1:g.530dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.4" sequenceAccession="NM_000094" sequenceVersion="4" change="c.2471dup" MANESelect="true">
            <Expression>NM_000094.4:c.2471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000085.1" sequenceAccession="NP_000085" sequenceVersion="1" change="p.Asn825fs">
            <Expression>NP_000085.1:p.Asn825fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.3" sequenceAccession="NM_000094" sequenceVersion="3" change="c.2470dupG">
            <Expression>NM_000094.3:c.2470dupG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_286" sequenceAccession="LRG_286">
            <Expression>LRG_286:g.11495dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_286t1" sequenceAccession="LRG_286t1">
            <Expression>LRG_286t1:c.2470dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_286p1" sequenceAccession="LRG_286p1" change="p.Asn825Lysfs">
            <Expression>LRG_286p1:p.Asn825Lysfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
        <XRef Type="rs" ID="746056280" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000094.4(COL7A1):c.2471dup (p.Asn825fs) AND Recessive dystrophic epidermolysis bullosa" Accession="RCV000018971" Version="28">
        <ClassifiedConditionList TraitSetID="5728">
          <ClassifiedCondition DB="MedGen" ID="C0079474">Recessive dystrophic epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1994-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.2471dup (p.Asn825fs) AND Epidermolysis bullosa dystrophica" Accession="RCV001835630" Version="2">
        <ClassifiedConditionList TraitSetID="8897">
          <ClassifiedCondition DB="MedGen" ID="C0079294">Epidermolysis bullosa dystrophica</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-11-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.2471dup (p.Asn825fs) AND not provided" Accession="RCV001388796" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-25" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.2471dup (p.Asn825fs) AND multiple conditions" Accession="RCV002496410" Version="2">
        <ClassifiedConditionList TraitSetID="11604">
          <ClassifiedCondition DB="MedGen" ID="C0268371">Dominant dystrophic epidermolysis bullosa with absence of skin</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1275114">Epidermolysis bullosa pruriginosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0432322">Generalized dominant dystrophic epidermolysis bullosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1843761">Nonsyndromic congenital nail disorder 8</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0432321">Pretibial dystrophic epidermolysis bullosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0079474">Recessive dystrophic epidermolysis bullosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1851573">Transient bullous dermolysis of the newborn</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.2471dup (p.Asn825fs) AND Generalized dominant dystrophic epidermolysis bullosa" Accession="RCV003318544" Version="2">
        <ClassifiedConditionList TraitSetID="5729">
          <ClassifiedCondition DB="MedGen" ID="C0432322">Generalized dominant dystrophic epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.2471dup (p.Asn825fs) AND COL7A1-related disorder" Accession="RCV003964804" Version="1">
        <ClassifiedConditionList TraitSetID="89973">
          <ClassifiedCondition>COL7A1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-26" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2013-04-04" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16971478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24210835</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29473190</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8088783</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9666834</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301481</ID>
          <ID Source="BookShelf">NBK1304</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5728" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0036" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Recessive dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Recessive+dystrophic+epidermolysis+bullosa/9208" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009179" DB="MONDO" />
                <XRef ID="48528004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hallopeau-Siemens Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">severe generalized recessive dystrophic epidermolysis bullosa</ElementValue>
                <Citation Type="general">
                  <ID Source="PubMed">18374450</ID>
                </Citation>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Distrophica Autosomal Recessive (RDEB)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RDEB</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EBR1</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6308" />
                <XRef ID="6308" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79408" DB="Orphanet" />
              <XRef ID="79409" DB="Orphanet" />
              <XRef ID="C0079474" DB="MedGen" />
              <XRef ID="MONDO:0009179" DB="MONDO" />
              <XRef Type="MIM" ID="226600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89973" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69901" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COL7A1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">COL7A1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL7A1- related disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="5729" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="14025" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Generalized dominant dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0007549" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB, generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB-gen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa dystrophica, autosomal dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBDD</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DDEB</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2139" />
                <XRef ID="2139" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="231568" DB="Orphanet" />
              <XRef ID="C0432322" DB="MedGen" />
              <XRef ID="MONDO:0007549" DB="MONDO" />
              <XRef Type="MIM" ID="131750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8897" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa dystrophica</ElementValue>
                <XRef ID="MONDO:0006543" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystrophic epidermolysis bullosa, Hallopeau-Siemens type (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Dystrophic+Epidermolysis+Bullosa/2423" DB="Genetic Alliance" />
                <XRef ID="254185007" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2150" />
                <XRef ID="2150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="303" DB="Orphanet" />
              <XRef ID="C0079294" DB="MedGen" />
              <XRef ID="MONDO:0006543" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="11604" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5019" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DEB, PRURIGINOSA</ElementValue>
                <XRef Type="MIM" ID="604129" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA PRURIGINOSA</ElementValue>
                <XRef Type="MIM" ID="604129" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa pruriginosa</ElementValue>
                <XRef ID="Epidermolysis+bullosa+pruriginosa/8317" DB="Genetic Alliance" />
                <XRef ID="403810008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16779" />
                <XRef ID="16779" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="89843" DB="Orphanet" />
              <XRef ID="C1275114" DB="MedGen" />
              <XRef ID="MONDO:0011398" DB="MONDO" />
              <XRef Type="MIM" ID="604129" DB="OMIM" />
            </Trait>
            <Trait ID="14025" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Generalized dominant dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0007549" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB, generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB-gen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa dystrophica, autosomal dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBDD</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DDEB</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2139" />
                <XRef ID="2139" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="231568" DB="Orphanet" />
              <XRef ID="C0432322" DB="MedGen" />
              <XRef ID="MONDO:0007549" DB="MONDO" />
              <XRef Type="MIM" ID="131750" DB="OMIM" />
            </Trait>
            <Trait ID="1603" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS</ElementValue>
                <XRef Type="MIM" ID="132000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, BART TYPE</ElementValue>
                <XRef Type="MIM" ID="132000" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dominant dystrophic epidermolysis bullosa with absence of skin</ElementValue>
                <XRef ID="2689001" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="C0268371" DB="MedGen" />
              <XRef ID="MONDO:0007557" DB="MONDO" />
              <XRef Type="MIM" ID="132000" DB="OMIM" />
            </Trait>
            <Trait ID="1599" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL</ElementValue>
                <XRef Type="MIM" ID="131850" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pretibial dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0007552" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pretibial epidermolysis bullosa</ElementValue>
                <XRef ID="HP:0012221" DB="Human Phenotype Ontology" />
                <XRef ID="67653003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pretibial blistering</ElementValue>
                <XRef ID="HP:0012221" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2155" />
                <XRef ID="2155" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79410" DB="Orphanet" />
              <XRef ID="C0432321" DB="MedGen" />
              <XRef ID="MONDO:0007552" DB="MONDO" />
              <XRef Type="MIM" ID="131850" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012221" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="6060" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TOENAIL DYSTROPHY, ISOLATED</ElementValue>
                <XRef Type="MIM" ID="607523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nonsyndromic congenital nail disorder 8</ElementValue>
                <XRef ID="MONDO:0011852" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NDNC8</ElementValue>
                <XRef Type="MIM" ID="607523" DB="OMIM" />
              </Symbol>
              <XRef ID="C1843761" DB="MedGen" />
              <XRef ID="MONDO:0011852" DB="MONDO" />
              <XRef Type="MIM" ID="607523" DB="OMIM" />
            </Trait>
            <Trait ID="4289" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Transient bullous dermolysis of the newborn</ElementValue>
                <XRef ID="Transient+bullous+dermolysis+of+the+newborn/7164" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007548" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, NEONATAL</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, NEONATAL FORM</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa dystrophica, dominant neonatal form</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TBDN</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10010" />
                <XRef ID="10010" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79411" DB="Orphanet" />
              <XRef ID="C1851573" DB="MedGen" />
              <XRef ID="MONDO:0007548" DB="MONDO" />
              <XRef Type="MIM" ID="131705" DB="OMIM" />
            </Trait>
            <Trait ID="1160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0036" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Recessive dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Recessive+dystrophic+epidermolysis+bullosa/9208" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009179" DB="MONDO" />
                <XRef ID="48528004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hallopeau-Siemens Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">severe generalized recessive dystrophic epidermolysis bullosa</ElementValue>
                <Citation Type="general">
                  <ID Source="PubMed">18374450</ID>
                </Citation>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Distrophica Autosomal Recessive (RDEB)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RDEB</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EBR1</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6308" />
                <XRef ID="6308" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79408" DB="Orphanet" />
              <XRef ID="79409" DB="Orphanet" />
              <XRef ID="C0079474" DB="MedGen" />
              <XRef ID="MONDO:0009179" DB="MONDO" />
              <XRef Type="MIM" ID="226600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4076642" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000094.4:c.2471dup|Dystrophic epidermolysis bullosa" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002079287" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.4:c.2471dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Dystrophic epidermolysis bullosa</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3115606" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4843933|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001589935" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16971478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9666834</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24210835</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29473190</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn825Lysfs*41) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). This variant is present in population databases (rs746056280, gnomAD 0.009%). This premature translational stop signal has been observed in individuals with autosomal recessive epidermolysis bullosa (PMID: 9666834, 24210835, 29473190). ClinVar contains an entry for this variant (Variation ID: 17425). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.48626190_48626191insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8865496" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="28006911|COL7A1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004782368" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The COL7A1 c.2471dupG variant is predicted to result in a frameshift and premature protein termination (p.Asn825Lysfs*41). This variant in the homozygous state or along with a second pathogenic variant in COL7A1 has been reported as causative for autosomal recessive epidermolysis bullosa (reported as c.2470insG in Salas-Alanis et al. 1998. PubMed ID: 9666834 and Warshauer et al. 2021. PubMed ID: 34435747; Saeidian et al. 2018. PubMed ID: 29473190). This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in COL7A1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.2471dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COL7A1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="39258" SubmissionDate="2012-05-01" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120120.0003_EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE" title="COL7A1, 1-BP INS, 2470G_EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000039258" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1994-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 35-year-old Hispanic male with recessive epidermolysis bullosa dystrophica (226600), Christiano et al. (1994) found compound heterozygosity for 2 nonsense mutations in the COL7A1 gene: a 1-bp insertion (2470insG) in exon 19, and a 1-bp deletion (3858delG; 120120.0004) in exon 31. Both mutations resulted in truncated proteins. Clinical features included extreme fragility of the skin and the mucous membranes of the upper gastrointestinal tract, leading to extensive mutilating scarring and joint contractures. Heterozygous family members were unaffected.</Attribute>
              <Citation>
                <ID Source="PubMed">8088783</ID>
              </Citation>
              <XRef DB="OMIM" ID="226600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <Name>COL7A1, 1-BP INS, 2470G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 2470G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120120.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5446048" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000094.4:c.2471dup|OMIM:131705;131750;131850;132000;226600;604129;607523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002791970" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.4:c.2471dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131705" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131750" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131850" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="132000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604129" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607523" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3535818" SubmissionDate="2022-06-22" DateLastUpdated="2023-03-04" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey="GDXSV:230703" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001802785" DateUpdated="2023-03-04" DateCreated="2021-08-21" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Reported to be the most frequent COL7A1 pathogenic variant in Hispanic Mexican populations (Salas-Alanis et al., 2000; Moreno-Trevino et al., 2014); Frameshift variant predicted to result in nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24210835, 16548289, 9666834, 29473190, 8088783, 10944088, 25308504)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:15428</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.2471dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_113_20220622054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_26_20210819132751</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7526817" SubmissionDate="2023-08-02" DateLastUpdated="2023-08-05" DateCreated="2023-08-05">
        <ClinVarSubmissionID localKey="NM_000094.3:c.2470dupG|OMIM:131750" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV004023206" DateUpdated="2023-08-05" DateCreated="2023-08-05" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="Bookshelf">NBK1304</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.2470dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131750" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13726645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5446048" TraitType="Disease" MappingType="XRef" MappingValue="226600" MappingRef="OMIM">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8865496" TraitType="Disease" MappingType="Name" MappingValue="COL7A1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="COL7A1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4076642" TraitType="Disease" MappingType="Name" MappingValue="Dystrophic epidermolysis bullosa" MappingRef="Preferred">
        <MedGen CUI="C0079294" Name="Epidermolysis bullosa dystrophica" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3535818" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446048" TraitType="Disease" MappingType="XRef" MappingValue="131705" MappingRef="OMIM">
        <MedGen CUI="C1851573" Name="Transient bullous dermolysis of the newborn" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="39258" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446048" TraitType="Disease" MappingType="XRef" MappingValue="607523" MappingRef="OMIM">
        <MedGen CUI="C1843761" Name="Nonsyndromic congenital nail disorder 8" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446048" TraitType="Disease" MappingType="XRef" MappingValue="131750" MappingRef="OMIM">
        <MedGen CUI="C0432322" Name="Generalized dominant dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446048" TraitType="Disease" MappingType="XRef" MappingValue="604129" MappingRef="OMIM">
        <MedGen CUI="C1275114" Name="Epidermolysis bullosa pruriginosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446048" TraitType="Disease" MappingType="XRef" MappingValue="131850" MappingRef="OMIM">
        <MedGen CUI="C0432321" Name="Pretibial dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7526817" TraitType="Disease" MappingType="XRef" MappingValue="131750" MappingRef="OMIM">
        <MedGen CUI="C0432322" Name="Generalized dominant dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3115606" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446048" TraitType="Disease" MappingType="XRef" MappingValue="132000" MappingRef="OMIM">
        <MedGen CUI="C0268371" Name="Dominant dystrophic epidermolysis bullosa with absence of skin" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

